Shimomura T, Murakami F, Kotani K, Ikawa S, Kono S
Department of Clinical Laboratory Medicine, Tottori University, Faculty of Medicine, Yonago, Japan.
Cephalalgia. 1999 May;19(4):218-22. doi: 10.1046/j.1468-2982.1999.019004218.x.
Nitric oxide (NO) is a candidate as a causative molecule in migraine. We determined nitrite, total nitrate/nitrite, and cyclic guanosine 3',5'-monophosphate (cGMP) concentrations in platelets from 30 migraine without aura (MwoA) patients and 17 migraine with aura (MwA) patients. All migraine patients were studied during their migraine attacks. The control group consisted of 28 healthy volunteers. Concentrations of platelet nitrite and total nitrate/nitrite were determined using simple and sensitive nitrate/nitrite fluorometric assay techniques. High concentrations of platelet nitrite and total nitrate/nitrite were found in patients with MwoA and MwA when compared with healthy controls. High concentrations of platelet cGMP were also found in patients with MwoA and MwA. The levels of platelet total nitrate/nitrite significantly decreased in headache-free periods after treatment with oral propranolol. These findings suggest that NO is produced in platelets during migraine attacks. It may also be related to the migrainous pain and the changes in cerebral blood flow experienced during migraine attacks. These data may provide new strategies for the treatment of migraine.
一氧化氮(NO)是偏头痛致病分子的一个候选因素。我们测定了30例无先兆偏头痛(MwoA)患者和17例有先兆偏头痛(MwA)患者血小板中亚硝酸盐、总硝酸盐/亚硝酸盐以及环磷酸鸟苷(cGMP)的浓度。所有偏头痛患者均在偏头痛发作期间接受研究。对照组由28名健康志愿者组成。采用简单且灵敏的硝酸盐/亚硝酸盐荧光测定技术测定血小板中亚硝酸盐和总硝酸盐/亚硝酸盐的浓度。与健康对照组相比,MwoA和MwA患者的血小板亚硝酸盐和总硝酸盐/亚硝酸盐浓度较高。MwoA和MwA患者的血小板cGMP水平也较高。口服普萘洛尔治疗后,在无头痛期血小板总硝酸盐/亚硝酸盐水平显著降低。这些发现表明,偏头痛发作期间血小板会产生NO。它也可能与偏头痛性疼痛以及偏头痛发作期间经历的脑血流变化有关。这些数据可能为偏头痛的治疗提供新策略。